about
Carcinoid myopathy and treatment with cyproheptadine (Periactin)Myopathy associated with anticonvulsant osteomalaciaNeurology and the gastrointestinal system.Thoracic radiculopathy related to collapsed thoracic vertebral bodiesVitamin D and its role in skeletal muscle.Reversible muscle weakness in patients with vitamin D deficiency25-hydroxycholecalciferol stimulation of muscle metabolism.Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial diseaseVitamin D hormone: a multitude of actions potentially influencing the physical function decline in older personsEffects of alkali supplementation and vitamin D insufficiency on rat skeletal muscle.Chronic antiepileptic toxicity: a review.Parathyroid adenomas associated with the malabsorption syndrome and chronic renal disease.Myopathy in Whipple's diseaseHypokalaemic myopathy following ileal resection.Clinical features and detection of osteomalacia in the elderly.Effects of parathyroid hormone on skeletal muscle protein and amino acid metabolism in the rat.Myopathy in hypophosphataemic osteomalacia presenting in adult life.Electromyography in nutritional osteomalacic myopathyOsteomalacia induced peripheral neuropathy after obesity reduction surgery.Vitamin D deficiency: subclinical and clinical consequences on musculoskeletal health.Vitamin D: an overview of its role in skeletal muscle physiology in children and adolescents.Vitamin D and the athlete: emerging insights.The effect of combined resistance exercise training and vitamin D3 supplementation on musculoskeletal health and function in older adults: a systematic review and meta-analysis.The neurological manifestations of malabsorptionElectromyography in infants and children.Vitamin D: new findings on its metabolism and its role in calcium nutrition.Recent advances in the unerstanding and management of metabolic bone disease.Tertiary hyperparathyroidism.Flaccid quadriparesis due to Salmonella enteritis.
P2860
Q24541426-07280838-8532-4A43-844E-1E369E839589Q28362792-37C652DA-A854-40B3-A1CC-90F55D4A9261Q32026840-D2645DC6-D494-478B-9E91-B611581C28D0Q33619672-2E643401-B5A7-473A-A210-00A407AB6718Q33983914-31F07350-127E-442D-A200-CB3543047212Q34187520-7CC1E467-4B65-4A77-ABD6-0515C17D0996Q34483799-3A40CAD2-201A-421E-853F-B63C019CA322Q34743333-69F707EA-AD4B-4585-8473-ED03884B328CQ35258854-006D3A48-C9B4-48B7-87E0-A9463436E6EAQ35619109-2C599E15-BE75-4FC7-89D3-D6919F2A3AB1Q36522161-19155B70-D3D5-4A86-B284-B376509A6237Q36619488-1D986FA2-1D17-48A3-930E-B1527ACB6FD7Q36663047-7AA63353-DE49-4B3F-B97D-9FB5C3510945Q36717141-873A762F-16BB-48BA-BB1F-B60ADEE93973Q36771456-A3EB23B4-D022-4A27-B18D-CC5CE0B00BEAQ36990365-206F4043-5BD3-4743-A904-C3A9566A2786Q37033616-CCCA5B92-171E-42B0-B1E8-70016290518FQ37044808-D533C296-7DDC-457E-B059-6DC4582CD531Q37345595-DF868825-2A71-420E-B335-29E11C0BAB9AQ37983513-C81322C9-B309-4A4B-9E3A-7382049AF034Q38040463-7D448431-177C-48AD-9923-044A6176E557Q38240651-D6EF1DA2-F423-4C84-9EAC-C74D21A6B26AQ38669251-A8D0E3AB-727A-4AB0-9D3A-9F3E53F17E6DQ39084028-D14A51BB-D14C-493E-961B-F2B80AA46B5DQ39509924-9037612E-3240-45A5-9951-1A8275CF937AQ39893841-EE7982DE-6667-4F20-903D-80E1FF86D75CQ39994316-3ED8020F-BBB9-40E2-BC03-A05FB14BE8ECQ49247214-80463AFC-E42C-420A-8847-B22BD533F99CQ50219335-F0784EE3-6E04-49F7-936D-C0162F772BA4
P2860
description
1967 nî lūn-bûn
@nan
1967年の論文
@ja
1967年学术文章
@wuu
1967年学术文章
@zh
1967年学术文章
@zh-cn
1967年学术文章
@zh-hans
1967年学术文章
@zh-my
1967年学术文章
@zh-sg
1967年學術文章
@yue
1967年學術文章
@zh-hant
name
Myopathy, osteomalacia and hyperparathyroidism.
@en
Myopathy, osteomalacia and hyperparathyroidism.
@nl
type
label
Myopathy, osteomalacia and hyperparathyroidism.
@en
Myopathy, osteomalacia and hyperparathyroidism.
@nl
prefLabel
Myopathy, osteomalacia and hyperparathyroidism.
@en
Myopathy, osteomalacia and hyperparathyroidism.
@nl
P356
P1433
P1476
Myopathy, osteomalacia and hyperparathyroidism.
@en
P304
P356
10.1093/BRAIN/90.3.593
P407
P577
1967-09-01T00:00:00Z